Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frauke Zipp

Showing results (281-290 of 317) with videos related to

Pageof 32
Sort By:
Molecular Psychiatry|May 28, 2024
Altered cortical synaptic lipid signaling leads to intermediate phenotypes of mental disordersOliver Tüscher, Muthuraman Muthuraman, Johann-Philipp Horstmann, et al.
Annals of Neurology|December 30, 2021
Subcortical Volumes as Early Predictors of Fatigue in Multiple SclerosisVinzenz Fleischer, Dumitru Ciolac, Gabriel Gonzalez-Escamilla, et al.
Pain|March 21, 2020
Longitudinal prevalence and determinants of pain in multiple sclerosis: results from the German National Multiple Sclerosis Cohort studyHenrik Heitmann, Bernhard Haller, Laura Tiemann, et al.
Ebiomedicine|May 28, 2020
Clinical implications of serum neurofilament in newly diagnosed MS patients: A longitudinal multicentre cohort studyStefan Bittner, Falk Steffen, Timo Uphaus, et al.
Cells|January 16, 2020
The Rare <i>IL22RA2</i> Signal Peptide Coding Variant rs28385692 Decreases Secretion of IL-22BP Isoform-1, -2 and -3 and Is Associated with Risk for Multiple SclerosisPaloma Gómez-Fernández, Aitzkoa Lopez de Lapuente Portilla, Ianire Astobiza, et al.
Neurogenetics|March 19, 2014
Assessment of microRNA-related SNP effects in the 3' untranslated region of the IL22RA2 risk locus in multiple sclerosisChristina M Lill, Marcel Schilling, Sara Ansaloni, et al.
Journal of Neurology|December 6, 2018
Can we predict cognitive decline after initial diagnosis of multiple sclerosis? Results from the German National early MS cohort (KKNMS)Andreas Johnen, Paul-Christian Bürkner, Nils C Landmeyer, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 8, 2018
Treatment choices and neuropsychological symptoms of a large cohort of early MSOlga von Bismarck, Theresa Dankowski, Björn Ambrosius, et al.
Therapeutic Advances in Neurological Disorders|September 11, 2023
Factors associated with depressive mood at the onset of multiple sclerosis - an analysis of 781 patients of the German NationMS cohortAnke Salmen, Robert Hoepner, Vinzenz Fleischer, et al.
Science Translational Medicine|January 21, 2026
In silico screening and preclinical validation identify bavisant as a therapeutic candidate for multiple sclerosisNadjet Gacem, Svetlana Bezukladova, Farina Windener, et al.
Pageof 32

Showing results (281-290 of 317) with videos related to

Sort By:
Pageof 32
Molecular Psychiatry|May 28, 2024
Altered cortical synaptic lipid signaling leads to intermediate phenotypes of mental disordersOliver Tüscher, Muthuraman Muthuraman, Johann-Philipp Horstmann, et al.
Annals of Neurology|December 30, 2021
Subcortical Volumes as Early Predictors of Fatigue in Multiple SclerosisVinzenz Fleischer, Dumitru Ciolac, Gabriel Gonzalez-Escamilla, et al.
Pain|March 21, 2020
Longitudinal prevalence and determinants of pain in multiple sclerosis: results from the German National Multiple Sclerosis Cohort studyHenrik Heitmann, Bernhard Haller, Laura Tiemann, et al.
Ebiomedicine|May 28, 2020
Clinical implications of serum neurofilament in newly diagnosed MS patients: A longitudinal multicentre cohort studyStefan Bittner, Falk Steffen, Timo Uphaus, et al.
Cells|January 16, 2020
The Rare <i>IL22RA2</i> Signal Peptide Coding Variant rs28385692 Decreases Secretion of IL-22BP Isoform-1, -2 and -3 and Is Associated with Risk for Multiple SclerosisPaloma Gómez-Fernández, Aitzkoa Lopez de Lapuente Portilla, Ianire Astobiza, et al.
Neurogenetics|March 19, 2014
Assessment of microRNA-related SNP effects in the 3' untranslated region of the IL22RA2 risk locus in multiple sclerosisChristina M Lill, Marcel Schilling, Sara Ansaloni, et al.
Journal of Neurology|December 6, 2018
Can we predict cognitive decline after initial diagnosis of multiple sclerosis? Results from the German National early MS cohort (KKNMS)Andreas Johnen, Paul-Christian Bürkner, Nils C Landmeyer, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 8, 2018
Treatment choices and neuropsychological symptoms of a large cohort of early MSOlga von Bismarck, Theresa Dankowski, Björn Ambrosius, et al.
Therapeutic Advances in Neurological Disorders|September 11, 2023
Factors associated with depressive mood at the onset of multiple sclerosis - an analysis of 781 patients of the German NationMS cohortAnke Salmen, Robert Hoepner, Vinzenz Fleischer, et al.
Science Translational Medicine|January 21, 2026
In silico screening and preclinical validation identify bavisant as a therapeutic candidate for multiple sclerosisNadjet Gacem, Svetlana Bezukladova, Farina Windener, et al.
Pageof 32